Asia FX muted, dollar fragile as CPI data boosts Sept rate cut bets
Investing.com - Pfizer reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Pfizer announced earnings per share of $0.93 on revenue of $14.58B. Analysts polled by Investing.com EPS of $0.7773 on revenue of $13.67B.
Pfizer 's are up 8% and is trading at $39.83 , still down 7.42% from its 52 week high of $43.02 set on Wednesday, December 9, 2020.
Pfizer follows other major Healthcare sector earnings this month
Pfizer's report follows an earnings beat by J&J on Tuesday, April 20, 2021, who reported EPS of $2.59 on revenue of $22.32B, EPS of $2.34 on revenue of $21.98B.
Novartis ADR had missed expectations on Tuesday, April 27, 2021 with first quarter EPS of $1.52 on revenue of $12.41B, for EPS of $1.54 on revenue of $12.5B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar